1,000+ Opportunities

Find the right grant

Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.

ActiveGlobal Genes · 2026

RARE Patient Impact Grant Program

Quick Facts

Agency: Global Genes
Funding: Unspecified
Deadline: Check Source
Status: Active
Eligibility: Rare disease patient advocacy organizations that are part of the Global Advocacy Alliance.

VerifiedGrant verified by AI review

✓ Award amounts confirmed

About This Grant

RARE Patient Impact Grant Program is sponsored by Global Genes. Provides grants to rare disease patient advocacy organizations that are part of the Global Advocacy Alliance to make specific, tangible differences for the communities they serve, including initiatives to develop educational tools and resources to improve health equity in underserved and underrepresented populations.

View Original RFP

Get alerted about grants like this

Save a search for “Global Genes” or related topics and get emailed when new opportunities appear.

Search similar grants →

Eligibility Requirements

Rare disease patient advocacy organizations that are part of the Global Advocacy Alliance.

Frequently Asked Questions

Who can apply for RARE Patient Impact Grant Program?

According to the current listing, eligibility includes: Rare disease patient advocacy organizations that are part of the Global Advocacy Alliance. Confirm the full requirements in the official notice before applying.

Who funds RARE Patient Impact Grant Program?

RARE Patient Impact Grant Program is funded by Global Genes. Verify program details on the funder's official page before applying.

How do I apply for RARE Patient Impact Grant Program?

Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.

Competitive Intelligence

Past winners and funding trends for this program

Full analysis

Funder Profile

Ready to start your proposal?

Granted drafts, reviews, and strengthens your grant application — saving weeks of work. Professional members win a grant in 12 months or get a full refund.

Browse More Grants

Backed by the Granted Guarantee

Similar Grants from Other Funders

National Cancer Institute (NCI)

VerifiedDeadline PassedBetween cycles

NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Not Allowed)

NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.

VariesDeadline: Jun 12, 2025 (passed)